Concepedia

Miranda van der Lee

MV

Statistics

Publications

2

Citations

174

H-Index

2

Active since

2014

Affiliations

Synthon (Netherlands)(Current)

Miranda van der Lee is an author at Synthon (Netherlands) specializing in antibody-drug conjugate therapy, oncology, and antibody-drug conjugates.

Publications per year

2014–2014

2

Publications

2

Preclinical Profile of the HER2-Targeting ADC SYD983/SYD985: Introduction of a New Duocarmycin-Based Linker-Drug Platform

Wim H.A. Dokter, Ruud Ubink, Miranda van der Lee et al. · Molecular Cancer Therapeutics · 2014 · 163 citations · Full text

, , +17

Toward clinical development of SYD985, a novel HER2-targeting antibody-drug conjugate (ADC).

Gijs Verheijden, Patrick H. Beusker, Ruud Ubink et al. · Journal of Clinical Oncology · 2014 · 11 citations

, , +17

1–2 of 2